Asmatanzeem Bepari
-
- Medicinal Plants and Neuroprotection 2
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions 3
-
- Drug-Induced Hepatotoxicity and Protection 3
- Microbial Natural Products and Biosynthesis 2
-
- Nanoparticles: synthesis and applications 6
-
- Natural product bioactivities and synthesis 3
-
- Pharmaceutical Practices and Patient Outcomes 3
-
- Essential Oils and Antimicrobial Activity 3
Asmatanzeem Bepari
27 papers receiving 403 citations
Peers
Comparison fields: 5 of 90
- Complementary and alternative medicine 67
- Toxicology 24
- Applied Microbiology and Biotechnology 13
- Pharmacology 38
- Biochemistry 25
Countries citing papers authored by Asmatanzeem Bepari
This map shows the geographic impact of Asmatanzeem Bepari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmatanzeem Bepari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmatanzeem Bepari more than expected).
Fields of papers citing papers by Asmatanzeem Bepari
This network shows the impact of papers produced by Asmatanzeem Bepari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmatanzeem Bepari. The network helps show where Asmatanzeem Bepari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Asmatanzeem Bepari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2021 | 28 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 76 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 15 | |
| 19 | 2019 | 4 | |
| 20 | 2016 | 1 |
About Asmatanzeem Bepari
Asmatanzeem Bepari is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Complementary and alternative medicine, having authored 32 papers that have together received 421 indexed citations. Recurring topics across this work include Nanoparticles: synthesis and applications (6 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Natural product bioactivities and synthesis (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Essential Oils and Antimicrobial Activity (3 papers), Medicinal Plants and Neuroprotection (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Complementary and alternative medicine (67 citations), Toxicology (24 citations) and Applied Microbiology and Biotechnology (13 citations). Asmatanzeem Bepari has collaborated with scholars based in Saudi Arabia, India and United States. Frequent co-authors include Shaik Kalimulla Niazi, Sreenivasa Nayaka, Shashiraj Kariyellappa Nagaraja, Rasha Assiri, Hassan A. Rudayni, Muthuraj Rudrappa, Dhanyakumara Shivapoojar Basavarajappa, Amal Alotaibi, Bidhayak Chakraborty and Ishrat Rahman. Their work appears in journals such as Materials, Applied Sciences and Nanomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.